Paradowska-Gorycka, A.; Stypinska, B.; Pawlik, A.; Malinowski, D.; Romanowska-Prochnicka, K.; Manczak, M.; Olesinska, M.
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis. Biomolecules 2019, 9, 355.
https://doi.org/10.3390/biom9080355
AMA Style
Paradowska-Gorycka A, Stypinska B, Pawlik A, Malinowski D, Romanowska-Prochnicka K, Manczak M, Olesinska M.
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis. Biomolecules. 2019; 9(8):355.
https://doi.org/10.3390/biom9080355
Chicago/Turabian Style
Paradowska-Gorycka, Agnieszka, Barbara Stypinska, Andrzej Pawlik, Damian Malinowski, Katarzyna Romanowska-Prochnicka, Malgorzata Manczak, and Marzena Olesinska.
2019. "KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis" Biomolecules 9, no. 8: 355.
https://doi.org/10.3390/biom9080355
APA Style
Paradowska-Gorycka, A., Stypinska, B., Pawlik, A., Malinowski, D., Romanowska-Prochnicka, K., Manczak, M., & Olesinska, M.
(2019). KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis. Biomolecules, 9(8), 355.
https://doi.org/10.3390/biom9080355